Bioxcel therapeutics to participate in the h.c. wainwright & co. “hcw@home” series

New haven, conn., aug. 13, 2025 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that vimal mehta, ph.d.
BTAI Ratings Summary
BTAI Quant Ranking